Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 410.90
Bid: 410.90
Ask: 411.00
Change: -7.30 (-1.75%)
Spread: 0.10 (0.024%)
Open: 415.20
High: 415.80
Low: 410.90
Prev. Close: 418.20
RTO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q3 Trading Update

19 Oct 2016 07:00

RNS Number : 8825M
Rentokil Initial PLC
19 October 2016
 

RENTOKIL INITIAL PLC (RTO)

THIRD QUARTER TRADING UPDATE

19 October 2016

 

 

 (£m)

Q3 2016

Growth

AER

AER

CER

Revenue

578.3

32.1%

15.7%

Revenue - ongoing operations1

576.7

33.1%

16.6%

 

 

Performance Overview (CER)

Revenue from ongoing operations increased by 16.6% in Q3, of which 3.1% was organic (H1 2016: 2.5%) and 13.5% was from acquisitions. Year to date we have delivered organic growth of 2.7%. Pest Control delivered an excellent performance in the quarter, growing organically by 5.9%, and our Hygiene business demonstrated further improvement, growing organically by 3.2%. Growth in our Emerging (+20.4%) and Growth (+26.3%) markets was once again particularly strong. Our operations within the Manage for Value quadrant grew by 2.3% while the rate of revenue decline in our Protect and Enhance markets was largely unchanged from Q1 and Q2 at 1%.

The majority of our regions have performed well in the period reflecting good performances in Asia, Pacific, Latin America, the UK and in our largest market, North America. While conditions remain tough in parts of Europe, particularly in France, overall the region delivered modest revenue growth in Q3.

Also in the quarter Rentokil was proud to provide in partnership with the Rio de Janeiro health authorities, Pest Control, including innovative mosquito elimination, in advance of and during the very successful Rio 2016 Olympic and Paralympic Games.

M&AThe Company acquired 13 businesses in the quarter including ten in Pest Control and two in Hygiene, as well as the acquisition of Residex, a Pest Control and Turf Products Distribution business, as announced on 7 July. All of the acquisitions were in Emerging or Growth markets. Combined annual revenues of the businesses acquired totalled £88m in the 12 months immediately prior to acquisition. For the nine months to 30 September we have acquired 33 businesses with combined annual revenues of £109m. The integrations of Steritech and Residex are both progressing well.

Commenting on today's announcement Andy Ransom, Chief Executive, said:

"I am pleased with our performance in the third quarter. Pest Control grew organically by almost 6%, reflecting good performances in Asia, Pacific, Latin America, the UK and our key growth market of North America. I am also encouraged by ongoing traction in our Hygiene business which delivered organic growth of 3.2%. Our guidance for the full year is unchanged."

Enquiries:

 

Investors / Analysts:

Katharine Rycroft

Rentokil Initial plc

07811 270734

Media:

Malcolm Padley

Rentokil Initial plc

07788 978 199

John Sunnucks

Bell Pottinger

0203 772 2549

 

 

 

AER - actual exchange rates; CER - constant 2015 exchange rates

 

1ongoing revenue excludes the financial performance of disposed and closed businesses but includes results from acquisitions

 

This announcement contains statements that are, or may be, forward-looking regarding the group's financial position and results, business strategy, plans and objectives. Such statements involve risk and uncertainty because they relate to future events and circumstances and there are accordingly a number of factors which might cause actual results and performance to differ materially from those expressed or implied by such statements. Forward-looking statements speak only as of the date they are made and no representation or warranty, whether expressed or implied, is given in relation to them, including as to their completeness or accuracy or the basis on which they were prepared. Other than in accordance with the Company's legal or regulatory obligations (including under the Listing Rules and the Disclosure and Transparency Rules), the Company does not undertake any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise. Information contained in this announcement relating to the Company or its share price, or the yield on its shares, should not be relied upon as an indicator of future performance. Nothing in this announcement should be construed as a profit forecast.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
QRTFMMMGVRFGVZM
Date   Source Headline
26th Mar 200810:59 amRNSHolding(s) in Company
20th Mar 20089:58 amPRNExternal Directorship
20th Mar 20087:01 amRNSDirectorate Change
11th Mar 20083:43 pmRNSHolding(s) in Company
5th Mar 200811:12 amRNSHolding(s) in Company
3rd Mar 200812:02 pmRNSHolding(s) in Company
28th Feb 20083:11 pmRNSDirector/PDMR Shareholding
28th Feb 20087:02 amRNSDirectorate Change
28th Feb 20087:02 amRNSFinal Results
15th Feb 200811:01 amRNSDirectorate Change
30th Jan 200812:21 pmRNSHolding(s) in Company
14th Jan 200811:08 amRNSDirectorate Change
11th Jan 20084:08 pmRNSHolding(s) in Company
10th Jan 200810:19 amRNSHolding(s) in Company
27th Dec 200710:11 amRNSDisposal
21st Dec 20079:57 amRNSHolding(s) in Company
20th Dec 200712:18 pmRNSDirector/PDMR Shareholding
18th Dec 20074:37 pmRNSDirector/PDMR Shareholding
14th Dec 20074:48 pmRNSHolding(s) in Company
14th Dec 200712:39 pmRNSDirector/PDMR Shareholding
13th Dec 20074:19 pmRNSDirector/PDMR Shareholding
13th Dec 20077:01 amRNSTrading Statement
12th Dec 200710:28 amRNSHolding(s) in Company
8th Nov 20077:01 amRNS3rd Quarter Results
19th Oct 200712:27 pmRNSAnnual Calendar 2008
17th Oct 20072:47 pmRNSHolding(s) in Company
8th Oct 20074:16 pmRNSDirector/PDMR Shareholding
1st Oct 20074:20 pmRNSTotal Voting Rights
28th Sep 20074:43 pmRNSDirector/PDMR Shareholding
25th Sep 200710:09 amRNSHolding(s) in Company
23rd Aug 20077:00 amRNSInterim Results
8th Aug 20072:57 pmRNSHolding(s) in Company
31st Jul 20079:50 amRNSTotal Voting Rights
30th Jul 200710:55 amRNSHolding(s) in Company
30th Jul 20077:01 amRNSAcquisition
19th Jul 20077:00 amRNSDirectorate Change
17th Jul 20077:00 amRNSAcquisition
9th Jul 200712:38 pmRNSHolding(s) in Company
2nd Jul 20074:27 pmRNSDisposal
29th Jun 200712:04 pmRNSHolding(s) in Company
27th Jun 20074:16 pmRNSRegulatory Inquiry Outcome
21st Jun 200710:47 amRNSHolding(s) in Company
11th Jun 200710:41 amRNSHolding(s) in Company
31st May 20074:27 pmRNSTotal Voting Rights
24th May 200710:01 amRNSHolding(s) in Company
3rd May 20075:50 pmRNSAGM Statement
2nd May 20077:01 amRNSTrading Update
1st May 20073:43 pmRNSTotal Voting Rights
24th Apr 20071:21 pmRNSCorporate Responsibility Rev
20th Apr 20078:00 amRNSDoc re. Company News

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.